BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ocker M. Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma. World J Gastroenterol 2020; 26(3): 279-290 [PMID: 31988589 DOI: 10.3748/wjg.v26.i3.279]
URL: https://www.wjgnet.com/1948-5182/full/v26/i3/279.htm
Number Citing Articles
1
Zhaoqiang Chen, Zepeng Zhang, Jiaqi Liu, Hongyu Qi, Jing Li, Jinjin Chen, Qingxia Huang, Qing Liu, Jia Mi, Xiangyan Li. Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside TransformationFrontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.853981
2
Shreya C. Pal, Stephany M. Castillo-Castañeda, Luis E. Díaz-Orozco, Mariana M. Ramírez-Mejía, Rita Dorantes-Heredia, Rogelio Alonso-Morales, Mohammed Eslam, Frank Lammert, Nahum Méndez-Sánchez. Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort StudyGenes 2023; 14(10): 1935 doi: 10.3390/genes14101935
3
Zhen Yang, Lin Wang. Current, emerging, and potential therapies for non-alcoholic steatohepatitisFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1152042
4
Magdelyn Mei-Theng Wong, Hui-Yin Chan, Norazlin Abdul Aziz, Thamil Selvee Ramasamy, Jan-Jin Bong, Ewe Seng Ch’ng, Subasri Armon, Suat-Cheng Peh, Sin-Yeang Teow. Interplay of autophagy and cancer stem cells in hepatocellular carcinomaMolecular Biology Reports 2021; 48(4): 3695 doi: 10.1007/s11033-021-06334-9
5
Peter Ellinghaus, Daniel Neureiter, Hendrik Nogai, Sebastian Stintzing, Matthias Ocker. Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?Cells 2022; 11(19): 3180 doi: 10.3390/cells11193180
6
Jarosław Jerzy Sak, Andrzej Prystupa, Paweł Kiciński, Dorota Luchowska-Kocot, Ewa Kurys-Denis, Hanna Bis-Wencel. Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosisWorld Journal of Hepatology 2021; 13(12): 2071-2080 doi: 10.4254/wjh.v13.i12.2071
7
Venkateswararao Eeda, Nikhil Yuvaraj Patil, Aditya Dilip Joshi, Vibhudutta Awasthi. Advancements in metabolic‐associated steatotic liver disease research: Diagnostics, small molecule developments, and future directionsHepatology Research 2024; 54(3): 222 doi: 10.1111/hepr.14008
8
Manjula Nandakumar, Abu Saleh Md Moin, Manjunath Ramanjaneya, Ahmed Al Qaissi, Thozhukat Sathyapalan, Stephen L. Atkin, Alexandra E. Butler. Severe iatrogenic hypoglycaemia modulates the fibroblast growth factor protein responseDiabetes, Obesity and Metabolism 2022; 24(8): 1483 doi: 10.1111/dom.14716
9
Olga Pavlova, Natalia Shevchenko, Sergey Pavlov, Tetiana Holovko, Liudmyla Bogmat. Predictors of fibrogenesis in children with JIA: a single-center pilot studyPediatric Rheumatology 2024; 22(1) doi: 10.1186/s12969-023-00937-1
10
Sachithra S. Ranaweera, Premkumar Natraj, Priyanka Rajan, Laksi A. Dayarathne, Suyama P. Mihindukulasooriya, Duong Thi Thuy Dinh, Youngheun Jee, Chang-Hoon Han. Anti-obesity effect of sulforaphane in broccoli leaf extract on 3T3-L1 adipocytes and ob/ob miceThe Journal of Nutritional Biochemistry 2022; 100: 108885 doi: 10.1016/j.jnutbio.2021.108885
11
Khaled A. Nematallah, Amgad Albohy, Noha Swilam. Phytotherapeutic approach to enhance the hepatoprotective activity of some edible plants: Molecular docking and nanoformulationJournal of Functional Foods 2024; 122: 106471 doi: 10.1016/j.jff.2024.106471
12
Chao Yang, Min Wan, Dengfeng Xu, Da Pan, Hui Xia, Ligang Yang, Guiju Sun. Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver AxisInternational Journal of Molecular Sciences 2021; 22(19): 10858 doi: 10.3390/ijms221910858